688197 Stock Overview
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of pharmaceutical drugs in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Shouyao Holdings (Beijing) Co., LTD. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥51.52 |
52 Week High | CN¥66.84 |
52 Week Low | CN¥26.81 |
Beta | 1.28 |
1 Month Change | 3.06% |
3 Month Change | 51.40% |
1 Year Change | -14.26% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 60.45% |
Recent News & Updates
Shareholder Returns
688197 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -1.1% | 5.6% | 3.1% |
1Y | -14.3% | -11.0% | -13.1% |
Return vs Industry: 688197 underperformed the CN Pharmaceuticals industry which returned -11% over the past year.
Return vs Market: 688197 underperformed the CN Market which returned -13.1% over the past year.
Price Volatility
688197 volatility | |
---|---|
688197 Average Weekly Movement | 11.9% |
Pharmaceuticals Industry Average Movement | 7.5% |
Market Average Movement | 8.6% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688197's share price has been volatile over the past 3 months.
Volatility Over Time: 688197's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | 168 | Wenjun Li | www.shouyaoholding.com |
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of pharmaceutical drugs in China. The company offers products for various indications, such as non-small cell lung cancer, lymphoma, hepatocellular carcinoma; pancreatic, breast, ovarian, and thyroid cancer; leukemia; and other diseases, such as diabetes.
Shouyao Holdings (Beijing) Co., LTD. Fundamentals Summary
688197 fundamental statistics | |
---|---|
Market cap | CN¥7.66b |
Earnings (TTM) | -CN¥191.79m |
Revenue (TTM) | CN¥5.23m |
1,465x
P/S Ratio-39.9x
P/E RatioIs 688197 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688197 income statement (TTM) | |
---|---|
Revenue | CN¥5.23m |
Cost of Revenue | CN¥111.31k |
Gross Profit | CN¥5.12m |
Other Expenses | CN¥196.91m |
Earnings | -CN¥191.79m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.29 |
Gross Margin | 97.87% |
Net Profit Margin | -3,667.74% |
Debt/Equity Ratio | 0.2% |
How did 688197 perform over the long term?
See historical performance and comparison